Impact of the ProbeFix on the Workflow of Pharmacological Stress Echocardiography Examinations

Amir Abbas Mahabadi

Status: Withdrawn

Conditions: Coronary Artery Disease

Treatments: Other: ProbeFix; Other: Manual hold

Study type: Interventional

Funder types: Other

Identifiers

NCT04016363

19-TEMP815870-BO

Details and patient eligibility

About

Pharmacological stress-echocardiography examinations are routinely performed in daily clinical practice. Usually, the echo probe is manually placed on the patient's thorax by the physician. The ProbeFix is a novel device, enabling the fixation of the ultrasound probe on the patient's thorax. Therefore, there is no need to manually hold the probe. This may improve the standardization of the examination and my reduce its duration. The present trial will investigate, whether the utilization of the ProbeFix reduces the duration of stress-echocardiography examinations and improves standardization of image acquisition.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients undergoing clinically indicated pharmacological stress-echocardiography
• Willingness to participate

Exclusion criteria

• Pharmacological stress echocardiography indication other than evaluation of stress induced ischemia (e.g. Low-Flow-Low-Gradient aortic valve stenoseis)
• poor image quality
• Early termination of the stress-echocardiography examination for clinical reasons

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups

ProbeFix arm

Experimental group

Description:

The echocardiography probe is fixated on the patient's thorax using the ProbeFix

Treatment:

Other: ProbeFix

Controll arm

Active Comparator group

Description:

The sonographer manually holds the probe on the patient's thorax

Treatment:

Other: Manual hold